What 4 Analyst Ratings Have To Say About Cardlytics
Portfolio Pulse from Benzinga Insights
Four analysts have provided ratings for Cardlytics (NASDAQ:CDLX) within the last quarter, with an average price target of $8.5, implying an upside from the current price of $5.555. The current average has increased by 30.77% from the previous average price target of $6.50.
June 06, 2023 | 8:02 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cardlytics (NASDAQ:CDLX) has received 4 analyst ratings within the last quarter, with an average price target of $8.5, indicating a potential upside from its current price of $5.555.
The article mentions that 4 analysts have provided ratings for Cardlytics (NASDAQ:CDLX) within the last quarter, with an average price target of $8.5, which is higher than the current price of $5.555. This implies a potential upside for the stock, which is likely to have a positive short-term impact on its price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100